Simvastatin and GGTI-2133, a geranylgeranyl transferase inhibitor, increase erythrocyte deformability but reduce low O(2) tension-induced ATP release.
about
Blood cells: an historical account of the roles of purinergic signallingBiological characterization of chemically diverse compounds targeting the Plasmodium falciparum coenzyme A synthesis pathwayPlasmodium falciparum ligand binding to erythrocytes induce alterations in deformability essential for invasionPoorly controlled type 2 diabetes is accompanied by significant morphological and ultrastructural changes in both erythrocytes and in thrombin-generated fibrin: implications for diagnosticsPurinergic control of red blood cell metabolism: novel strategies to improve red cell storage quality.
P2860
Simvastatin and GGTI-2133, a geranylgeranyl transferase inhibitor, increase erythrocyte deformability but reduce low O(2) tension-induced ATP release.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Simvastatin and GGTI-2133, a g ...... ) tension-induced ATP release.
@ast
Simvastatin and GGTI-2133, a g ...... ) tension-induced ATP release.
@en
type
label
Simvastatin and GGTI-2133, a g ...... ) tension-induced ATP release.
@ast
Simvastatin and GGTI-2133, a g ...... ) tension-induced ATP release.
@en
prefLabel
Simvastatin and GGTI-2133, a g ...... ) tension-induced ATP release.
@ast
Simvastatin and GGTI-2133, a g ...... ) tension-induced ATP release.
@en
P2093
P2860
P1476
Simvastatin and GGTI-2133, a g ...... ) tension-induced ATP release.
@en
P2093
A H Stephenson
M L Ellsworth
R S Sprague
P2860
P304
P356
10.1152/AJPHEART.00635.2012
P577
2013-01-18T00:00:00Z